Each year, thanks to inconclusive tests for thyroid cancer, thousands of people undergo unnecessary surgeries to remove part or all of their thyroids. A new test based on the unique chemical fingerprints of thyroid cancer might change that. It's faster and about two-thirds more accurate than the diagnostic tests doctors use today.
Read moreOregon Medicaid enrollees are less likely to make unscheduled trips to the hospital following the implementation of the state's accountable-care model, new research shows.
Read moreResearchers, using a method called genome-wide association study, have illuminated the genetic underpinnings of high serum urate, the blood condition that brings on gout. The study will inform efforts to develop screening tests for gout risk as well as potential new treatments.
Read moreSmelly flatulence is one way our bodies manage our well-being. It turns out expelling noxious gas takes priority in our guts.
Read moreFindings showcasing a connection between bacteria in the microbiome and colon cancer, which may be used to screen younger populations at risk.
Read moreResearchers have developed a new non-invasive optical imaging system that promises to improve diagnosis and treatments for dry eye disease. Dry eye, which often causes irritation and blurred vision, occurs when there is instability in the inner layer of the tear film that protects the outside of the eye.
Read moreA researcher's prototype smartphone app — designed to help parents detect early signs of various eye diseases in their children such as retinoblastoma, an aggressive pediatric eye cancer — has passed its first big test.
Read moreIn a recent study, researchers discovered that if children had a low birth weight, they were more likely to exhibit cardiovascular risk factors in fifth grade.
Read moreA new test to determine whether antibiotics will be effective against certain bacterial infections is helping physicians make faster and better prescription treatment choices.
Read moreTwo new studies report progress in using stem cells to develop new therapies for Pelizaeus-Merzbacher disease (PMD), a rare genetic condition affecting boys that can be fatal before 10 years of age.
Read more